These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 15125388

  • 1. [Intermittent intravenous administration of cyclophosphamide in patients with lupus nephritis].
    Morović-Vergles J, Galesić K, Dancuo I, Vergles D.
    Acta Med Croatica; 2004; 58(1):13-7. PubMed ID: 15125388
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 3. [Lupus nephritis: retrospective analysis of the course of the disease].
    Djukanović L, Pavlović S, Blagojević R, Dimitrijević J, Stojsic T, Ratković M, Kazić K, Lezaić V, Naumović R.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
    [Abstract] [Full Text] [Related]

  • 4. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K, Tapaneya-Olarn C, Tapaneya-Olarn W.
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [Abstract] [Full Text] [Related]

  • 5. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN.
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [Abstract] [Full Text] [Related]

  • 6. The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment.
    Kim YG, Kim HW, Cho YM, Oh JS, Nah SS, Lee CK, Yoo B.
    Rheumatology (Oxford); 2008 Mar; 47(3):311-4. PubMed ID: 18204087
    [Abstract] [Full Text] [Related]

  • 7. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [Abstract] [Full Text] [Related]

  • 8. Pulse cyclophospamide in severe lupus nephritis: Southern Indian experience.
    Das U, Dakshina Murty KV, Prasad N, Prayag A.
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):372-8. PubMed ID: 20228536
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.
    Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
    [Abstract] [Full Text] [Related]

  • 10. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
    Yee CS, Gordon C, Dostal C, Petera P, Dadoniene J, Griffiths B, Rozman B, Isenberg DA, Sturfelt G, Nived O, Turney JH, Venalis A, Adu D, Smolen JS, Emery P.
    Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482
    [Abstract] [Full Text] [Related]

  • 11. [Intravenous cyclophosphamide in lupus nephritis: twenty years reducing dose].
    Frutos MA, Martín Gómez A, de Ramón E, Camps MT, Valera A, García I, Fernández Nebro A.
    Nefrologia; 2007 May; 27(1):12-22. PubMed ID: 17402875
    [Abstract] [Full Text] [Related]

  • 12. Longterm followup of childhood lupus nephritis.
    Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, Eddy A, Gladman D, Urowitz M, Hebert D, Silverman E.
    J Rheumatol; 2002 Dec; 29(12):2635-42. PubMed ID: 12465165
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of the diffuse and focal proliferative forms of lupus nephropathy with intravenous cyclophosphamide. Intravenous cyclophosphamide in systemic lupus erythematosus].
    Vigil A, Gallar P, Oliet A, Ortega O, Bajo MA.
    Rev Clin Esp; 1995 Aug; 195(8):524-9. PubMed ID: 7569197
    [Abstract] [Full Text] [Related]

  • 14. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria.
    Gunnarsson I, Sundelin B, Heimbürger M, Forslid J, van Vollenhoven R, Lundberg I, Jacobson SH.
    J Rheumatol; 2002 Apr; 29(4):693-9. PubMed ID: 11950009
    [Abstract] [Full Text] [Related]

  • 15. [Lupus nephritis in children and adolescents: therapy, clinical course and prognosis].
    Bogdanović R, Nikolić V, Ognjanović M, Dimitrijević J, Marković-Lipkovski J, Pasić S, Minić A, Stajić N.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():6-12. PubMed ID: 12583307
    [Abstract] [Full Text] [Related]

  • 16. Treatment and renal outcome of lupus nephritis: single center experience.
    Go KW, Teo SM.
    Med J Malaysia; 2006 Oct; 61(4):447-50. PubMed ID: 17243522
    [Abstract] [Full Text] [Related]

  • 17. Outcome of 85 lupus nephritis patients treated with intravenous cyclophosphamide: a single centre 10 year experience.
    Chan AY, Hooi LS.
    Med J Malaysia; 2000 Mar; 55(1):14-20. PubMed ID: 11072485
    [Abstract] [Full Text] [Related]

  • 18. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A, Radhakrishnan J, Estes D, D'Agati V, Kopelman R, Pernis A, Flis R, Pirani C, Appel GB.
    Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors of diffuse proliferative lupus nephritis.
    Lim CS, Chin HJ, Jung YC, Kim YS, Ahn C, Han JS, Kim S, Lee JS.
    Clin Nephrol; 1999 Sep; 52(3):139-47. PubMed ID: 10499308
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.